Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management

The authors aim to address the diagnosis and management of metabolic dysfunction-associated steatotic liver disease (MASLD), a prevalent cause of chronic liver disease linked to cardiometabolic risk factors. They emphasize the importance of risk stratification and noninvasive screening for advanced fibrosis, as well as the role of lifestyle interventions and FDA-approved medications in improving patient outcomes. The article highlights the need for primary care monitoring to mitigate long-term complications associated with MASLD.